Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Case ReportsCase Reports
Open Access

Effects of a Greek Yoghurt-based Complex on the Human Facial Skin Microbiome

IOANNIS VOYIATZIS, GIANNIS VATSELLAS, DIMITRIS VALAKOS, GEORGIOS STAVROPOULOS, AGGELIKI LAMIA, CHRYSSOULA STAMATOGIANNI, EMMANOUIL ATHANASIADIS, ATHANASIOS K. ANAGNOSTOPOULOS and LIDA ALEXIOU
In Vivo May 2026, 40 (3) 1852-1863; DOI: https://doi.org/10.21873/invivo.14339
IOANNIS VOYIATZIS
1Multi-Omics Laboratory, Center of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GIANNIS VATSELLAS
1Multi-Omics Laboratory, Center of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DIMITRIS VALAKOS
1Multi-Omics Laboratory, Center of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GEORGIOS STAVROPOULOS
2Korres SA- Natural Products, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AGGELIKI LAMIA
2Korres SA- Natural Products, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRYSSOULA STAMATOGIANNI
2Korres SA- Natural Products, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EMMANOUIL ATHANASIADIS
1Multi-Omics Laboratory, Center of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ATHANASIOS K. ANAGNOSTOPOULOS
1Multi-Omics Laboratory, Center of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece;
3Oncology Unit, Third Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LIDA ALEXIOU
2Korres SA- Natural Products, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lida.alexiou{at}korres.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Natural ingredient-containing complexes are used in dermo-cosmetics to ameliorate facial characteristics, yet human experimental approaches and trials demonstrating their efficacy remain limited. This study assessed the effects of a Greek yoghurt-based complex on the human facial skin microbiome.

Materials and Methods: Thirty-one volunteers (27 females, 4 males; 20-65 years) with stressed facial skin and 15 volunteers (10 females, 5 males) with balanced skin were enrolled in a 28-day clinical study. At baseline, skin swabs were collected from both groups. Participants with stressed skin were treated in a split-face design with a yoghurt-based complex applied to the right cheek and placebo to the left cheek for 28 days, with follow-up sampling on days 7, 14, and 28. Bacterial DNA was analyzed by 16S rRNA gene amplicon sequencing. Bioinformatic analyses assessed microbial composition, diversity, and relative abundance. Baseline differences between skin types and treatment effects versus placebo were evaluated over time.

Results: A lowered microbiota diversity was observed in “stressed” facial skin, compared to the “balanced” group, on day 0. The four most abundant microbiota genera were Corynebacterium, Propionibacterium, Staphylococcus and Actinomyces spp. A significant difference in the relative abundance of these species was noted in the two groups (stressed vs. balanced) at baseline, as well as a consistent increase in mean bacterial diversity after intervention with the yogurt-based complex.

Conclusion: A gradual restoration of the skin’s microbial balance essential for a healthy skin function and appearance, was noted following the yoghurt-based complex application.

Keywords:
  • Facial skin
  • microbiome
  • yoghurt-based complex
  • NGS
  • 16S rRNA sequencing
  • skin amelioration

Introduction

The human skin is the largest organ of the body, extending across the whole outer surface of the body and separating it from the external environment. It has an important, multifunctional role, which includes physical and immunological protection, sensation, endocrine-exocrine activity, along with assisting in the regulation of the body temperature and water balance (1). The protective barrier it forms against the environment serves as the organism’s first line of defence against physical injury and external aggressors, such as ultraviolet radiation, pollutants, pathogens and other toxins (2).

At the same time, skin provides a natural habitat for a myriad of microbes that comprise the “skin microbiome” (3, 4). The skin microbiome is defined as the sum of the genetic material of all the microorganisms present on the human skin (5). Resident microorganisms that colonize the skin, also known as skin microbiota, play an important role in maintaining the physiochemical balance of the skin (6). A balanced and diverse skin microbiota population, which includes viruses, fungi and bacteria, interacts synergistically with the skin to protect the host from pathogens and boost the immune system’s response by continuously training it (4, 7).

Human skin and in particular skin on the face contains a higher density of sebaceous glands, which help lubricate and protect the skin, but, also, make it more susceptible to oiliness, clogged pores and acne (5, 8). Healthy facial skin ecosystems contain mostly microorganisms that can tolerate these lipophilic, anaerobic conditions, such as Propionibacterium spp. (also known as Cutibacterium), Corynebacterium spp., Staphylococci spp., Demodex mites, Malassezia fungi and Propionibacterium phages (4, 6, 9-11). The microbiota communities that colonize the human face determine the skin’s physiochemical and physiological balance, ensuring its health and homeostasis, host immune defence, and its appearance (12). A heathy or “balanced” facial microbiome contributes to homeostatic mechanisms that fortify the skin’s barrier function, promoting hydration and overall wellbeing (13).

Disruption of this delicate microbial balance results in dysbiosis, a precursor of skin disease (14, 15). A plethora of factors may lead to dysbiosis, thereby potentially causing the facial skin to appear “stressed” and unhealthy. Internal factors include age, sex, hormones and genetics, whereas external causes comprise stress-inducing factors to the skin like poor hygiene, harsh cosmetic products, physical and psychological stress, diet, chemical exposure and medications (16, 17).

Recent dermatological research has increasingly focused on products with ingredients of natural origin to ameliorate characteristics of the human face with minimally invasive techniques (18-20). The development of microbiome-based formulations, such as bioactive compounds, pro- and prebiotics, has become of central focus in efforts to preserve skin homeostatic mechanisms. (21-24). These products have emerged as innovative options for cosmetic applications (22, 25, 26). For instance, Le et al. demonstrated the clinical anti-aging potential of caviar oil-derived products, highlighting the skin’s responsiveness to bioactive lipids and proteins (21). However, controlled experimental trials demonstrating their efficacy, mechanism of action and safety in human facial skin remain limited (22-24, 27, 28).

Advancements in the fields of genomics and bioinformatics and, more specifically, the consolidation of next generation sequencing (NGS) as the go-to tool in the study of microbiota have allowed the characterization of the skin’s microbiome in great detail (29, 30). Nowadays, bacteria are mostly analysed either by marker gene sequencing, e.g., 16S amplicon sequencing, or by whole-genome sequencing (shotgun sequencing). 16S RNA sequencing is widely used to determine the composition, abundance and diversity of the bacterial communities present in a sample without the need for further culturing (31, 32).

The aim of the study was to assess the effects of a Greek yoghurt-based complex on the human facial skin microbiome by plotting and characterizing bacterial flora using NGS of 16S bacterial ribosomal rRNA.

Materials and Methods

Yoghurt-based complex composition.

The yoghurt-based complex consisted of the following ingredients: (i) Greek Yoghurt: a cultured dairy product made by bacterial fermentation of milk, followed by a straining process to remove acid whey, resulting in a thicker texture and high protein count. This procedure concentrates its natural components, making it rich in proteins, minerals, lactic acid, vitamins, bioactive metabolites and active acid bacteria; (ii) An ingredient mix based on pre- and pro-biotics containing Alpha glucan-oligosaccharide, Polymnia sonchifolia root juice, Maltodextrin and inactivated Lactobacilli (L. casei and L. acidophilus); (iii) An ingredient mix based on marine algae extracts containing glycerin, water, seawater, Laminaria digitata extract, Chlorella vulgaris extract, saccharide isomerate and phenethylalcohol; and (iv) An ingredient mix based on oat milk containing water, glycerin, Avena Sativa (Oat) kernel extract, glyceryl oleate citrate and caprylic/capric triglyceride.

Study design. This was a 28-day, prospective, split-face clinical and microbiome study evaluating the effect of a topical active-complex formulation on facial skin. Participants applied the placebo cream (identical in formulation to the active-complex cream with absence of active ingredients) to the left cheek and the active-complex cream to the right cheek once daily throughout the study period.

Microbiome assessment and study groups. The effects of the yoghurt-based complex on the facial skin microbiome were evaluated by profiling bacterial communities in volunteers with “balanced” and “stressed” skin using next-generation sequencing of the 16S rRNA gene. The balanced-skin group served as a microbiome reference cohort and was sampled once at baseline (D0). Volunteers with stressed skin were sampled at baseline (D0) and subsequently followed longitudinally at D7, D14 and D28. After baseline sampling, the stressed-skin cohort was assigned in a split-face design to receive either the yoghurt-based complex or a placebo formulation, allowing comparison of microbiome changes over time between treatment conditions.

Participants and recruitment. A total of 31 adults with clinically assessed sensitive skin (27 females, four males; age range=20-65 years) were enrolled (Table I). In addition, 15 normal-skin subjects (10 females, 5 males) were included at baseline as a microbiome reference cohort (Table II) (Figure 1). From this group n=5 volunteers were subjected to emulsion check (sensory evaluation via 24-h patch test).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Demographic and skin characteristics of volunteers in the stressed skin group.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Demographic and skin characteristics of the microbiome reference group with normal skin.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Study flowchart. Study design and sampling scheme of the 28-day split-face clinical and microbiome study. A cohort of volunteers with stressed facial skin was sampled at baseline (D0) and subsequently assigned in a split-face design to receive the yoghurt-based complex on the right cheek and a placebo formulation on the left cheek, applied once daily for 28 days. Facial skin swab samples were collected from both cheeks at D0, D7, D14, and D28. A separate cohort of volunteers with balanced (normal) skin was included solely as a microbiome reference group and was sampled only once at baseline (D0), without receiving any topical treatment. IND: Individuals.

Patient selection, recruitment and enrollment as well as the clinical part of the study took place in the QACS Laboratory, Athens, Greece. Stressed skin status was confirmed by a board-certified dermatologist based on medical history, self-reported cutaneous hyperreactivity (stinging, burning, itching, tightness), and absence of visible inflammatory dermatosis at baseline. Stressed skin was defined as heightened neurosensory and barrier-related reactivity to environmental and cosmetic stimuli.

Participants were recruited from the laboratory’s volunteer registry. Eligibility was deemed based on predefined criteria, including no active dermatologic disease, no systemic therapy affecting skin function, and no antibiotic use within 30 days prior to enrollment. All participants provided written informed consent prior to study participation.

Skin sampling. Facial microbiome samples were collected at designated timepoints using a standardized, controlled swabbing protocol. Volunteers refrained from facial cleansing and topical product application for at least 12 hours prior to sampling. Sterile flocked swabs (4N6FLOQSwab®, Copan, Brescia, Italy) pre-moistened with 500 μl DNA-free buffer (0.15 M NaCl, 0.1% Tween-20) were used to sample a defined 4 cm2 area on each cheek.

To ensure sampling consistency, each site was swabbed with 40 strokes total: 20 horizontal (left/right) and 20 vertical (up/down), applied at ~75 g force (acceptable 50-100 g) and ~2 cm/s. The swab was rotated 90° every 5 strokes to expose fresh fibers. Pressure and motion parameters were standardized via operator training using a digital scale and a marked 2-cm guide path prior to study initiation. Total contact time per site was approximately 40 sec. Swabs were immediately placed into sterile tubes containing lysis buffer, transported on ice, and stored at −80°C until DNA extraction. Field blanks were collected during each sampling session to monitor environmental and reagent contamination.

Bacterial DNA extraction. Total DNA extraction from frozen swab samples was carried out with the co-application of enzymatic and mechanical lysis using the DNeasy Blood & Tissue kit (Qiagen, Milan, Italy), according to the manufacturer’s instructions. Approximately 180 μl of tissue lysis buffer were added directly to the frozen samples and vortexed for 60s to maximize microbial transfer from the swabs into the solution. To ensure thorough cell lysis, swabs were removed, and samples were bead-beaten at 30 Hz for 1 min using the Tissue Lyzer II (Qiagen, Germantown, MD, USA). Subsequently, samples were incubated with 20 μl proteinase K for 3 h at 56°C. The remaining bacterial DNA isolation steps were performed according to instructions from the DNeasy Blood & Tissue kit.

16S rRNA sequencing. Standard Illumina MiSeq® protocols were used for 16S metagenomic sequencing library preparation. For the amplification of the 16S rRNA gene variable V3-V4 regions, a total of 125 ng isolated microbial genomic DNA per sample was dispensed into a 96-well plate. PCR protocols were followed as recommended by the manufacturer using the suggested V3-V4 primer pairs. Initially, microbial DNA was used for a 25 μl PCR reaction containing 2× KAPA High Fidelity HotStart Ready Mix (Roche, Mannheim, Germany) and PCR primers specific to the studied hypervariable region. Thermal cycling conditions were 95°C for 3 min for the initial denaturation, followed by 25 cycles of denaturation at 95°C for 30 s, annealing at 55°C for 30 s, and extension at 72°C for 30 s. A further extension step was carried out for 5 min at 72°C, followed by a cooling step to 4°C. A purification step of the V3, V4 hypervariable region amplicons was then carried out and Illumina sequencing adapters were attached by a 50 μl PCR reaction using the Nextera XT Index Kit (Illumina, San Diego, CA, USA). A purification step was repeated prior to library validation and quantification. Quality control of the libraries was carried out using the Agilent bioanalyzer DNA1000 kit and DNA quantitation with the PicoGreen fluorometric assay (Agilent, Santa Clara, CA, USA). Approximately 250 Million 2×300 bp Paired-End reads were generated using the Illumina MiSeq Sequencer.

Data analysis. Sequencing quality was assessed and corrected using the Trim Galore software package (33). To investigate the microbial community identified by the 16S gene sequencing, demultiplexed paired end FASTQ files were analysed with the Mothur software package (version 1.48.0), following the standardised MiSeq SOP (34). Paired-end raw sequence forward and reverse reads were merged using standard settings and sequences containing ambiguous data were removed in a quality control step. Sequences were then filtered towards removing duplicates prior to alignment to the reference database. Taxonomy of gene sequences was assigned using the SILVA bacterial reference database (version 102).

Bacterial community diversity was assessed using the Simpson diversity index. The mean community diversity for each group was calculated as the average Simpson index across samples.

Statistical analysis. All statistical analyses were performed using the ggplot2 software package, a graphical user interface for R version 3.2.2 (The R Foundation for Statistical Computing, Vienna, Austria). Relative abundance of major taxonomic groups was estimated as the ratio of sequence abundance to the total number of sequences identified in each sample and expressed as mean±standard deviation (SD) for each group. Comparisons of mean community diversity and mean relative abundance across all three study groups (“stressed”, “balanced”, “placebo”) and statistical significance was defined as p<0.05 (35).

Ethics statement. This study was conducted in accordance with the principles of the Declaration of Helsinki and Good Clinical Practice (GCP) guidelines. Personal data were handled in compliance with GDPR (EU 2016/679) regulations, and all samples were pseudonymized prior to analysis to ensure participant confidentiality.

Results

Effects on skin microbiome. Analysis of 16S rRNA sequencing data revealed clear differences in bacterial community structure between balanced and stressed facial skin at baseline. Stressed skin exhibited significantly reduced microbial diversity compared to balanced skin, a pattern that progressively changed following application of the yoghurt-based complex. Longitudinal analysis across the four study time points (D0, D7, D14, and D28) demonstrated a statistically significant increase in bacterial diversity in the complex-treated skin, whereas no comparable changes were observed in the placebo-treated sites.

Taxonomic profile of facial skin bacteria. The microbiota genera with high representation were detected via 16s rRNA sequencing and the four most abundant included Corynebacterium, Propionibacterium, Staphylococcus, and Actinomyces spp., consistent with the findings reported in current literature (10, 36). There was a significant difference in the relative frequency of Corynebacterium, Propionibacterium, Staphylococcus, and Actinomyces among the “balanced” and “stressed” groups (p<0.05). In order to better compare these differences, the mean relative abundance was calculated. Deregulation of facial skin microbiome was evident, as reflected by the increase in mean relative abundance of Corynebacterium spp. and Staphylococcus spp. in “stressed” skin swabs. On the contrary, a significant decrease in the mean relative abundance of Propionibacterium spp. and Actinomyces was displayed in “stressed” skin swabs compared to those of the “balanced” group. Continued application of the complex resulted in the relative abundance of all four microbiota genera to gradually approach normal levels, accomplishing the best results on D28 (28 days post complex application), where their abundance resembled the levels of “balanced” skin (Figure 2).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Differences in the relative abundance of four major skin bacteria genera. Box plots showing the relative abundance of (A) Corynebacterium spp., (B) Propionibacterium spp., (C) Staphylococcus spp. and (D) Actinomyces spp. over the course of the study associated with yoghurt-based Complex and Placebo application on volunteer’s facial skin. Statistically significant at *p<0.05.

More specifically, following the application of the complex, the proportion of Corynebacterium bacteria compared to the total bacterial population in “stressed” skin swabs decreased from 5% on D0 to 3% on D28, in comparison with the 3% displayed on the “balanced” group (Figure 2A). Meanwhile, Propionibacterium spp. showed a remarkable progression increasing from 3% in “stressed” facial skin samples on D0 to 18% in the “complex” samples on D28, compared to the 19% present in the “balanced” group (Figure 2B). Staphylococcus bacteria in the “stressed” group decreased from 15% on D0 to 8% on D28, compared to the 9% of the “balanced” group (Figure 2C). Finally, Actinomyces spp. increased from 0.09% in the “stressed” group on D0 to 0.25% on D28 after the complex’s application, in comparison with 0.3% of the “balanced” samples (Figure 2D). It becomes evident that the application of the yogurt-based complex contributed to the bacterial population reaching “balanced” benchmarks over time. Such results were not evident in the “placebo” group where either the species’ percentages remained virtually the same as the “stressed” samples (Propionibacterium spp., Actinomyces spp.) or their populations became even more excessive (Corynebacterium spp. and Staphylococcus spp.), further disrupting the microbial ecosystem.

Bacterial community diversity before and after application. Bacterial community diversity was assessed using the Simpson Diversity Index. This showed distinctive differences between the volunteer groups. “Balanced” skin volunteers on D0 had a mean diversity index of 0.57±0.05, while the “Stressed” skin group exhibited a significantly lower mean index of 0.29±0.02. The “Stressed” group was then split into the “Complex” and “Placebo” groups, based on whether the complex or a placebo was applied on D7, D14 and D28. The mean index of the “Complex” group steadily increased after the application reaching 0.53±0.04 on the final day, while the “Placebo” group index remained unchanged at 0.25±0.03. The difference between all groups studied was statistically significant (p<0.05). Bar plot analysis demonstrates an upward shift in the median diversity of the “Complex” group compared to the “Placebo” group over time (Figure 3A). This shift is better depicted in a line chart displaying the mean community diversity over time, comparing the effects of Complex and Placebo application on volunteers’ facial skin (Figure 3B). Intervention with the yogurt-based complex could be associated with a consistent increase in mean bacterial community diversity, gradually restoring the facial skin’s microbiome balance. On the contrary, placebo application shows no improvements in biodiversity, with the mean diversity index remaining constantly on the same level as the “stressed” group.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Characterization of bacterial community diversity in facial skin swab samples. (A) Bar plot of community diversity across all study time points and study conditions (Balanced, Stressed, yoghurt-based Complex, Placebo) as estimated using the Simpson Diversity Index. (B) Alterations in mean community diversity over time as an effect of yoghurt-based Complex and Placebo application on volunteer’s facial skin. Statistically significant at *p<0.05.

Discussion

The facial microbiome plays a central role in maintaining the physiochemical balance of the skin, which is easily disturbed by lifestyle-related stimuli (6). When the skin microbiota balance is disrupted, this can lead to appearance alteration and high risk for abnormal skin conditions (16, 17, 37-39). Among the stressful factors for the skin are modern day skincare products that often rely on chemical-based compounds and even though are considered safe and meet regulatory standards, frequent use may change the skin’s metabolome and microbiome (40). Other factors include genetics, poor hygiene, stress or toxins exposure.

In order to study the effects of yogurt-based complex on an imbalanced human facial microbiome, the bacterial diversity on healthy and stressed skin was determined using NGS of the 16S bacterial ribosomal rRNA gene. This study showcases that the major genera detected in balanced skin were Propionibacterium, Staphylococcus, Corynebacterium, and Actinomyces. The most significant differences regarding the relative frequency of bacteria in balanced skin compared to the “stressed” samples were, also, mostly displayed in these four major genera. Corynebacterium spp. and Staphylococcus spp. concentrations displayed a statistically significant increase in “stressed” skin swabs, while a significant decrease was evident in the populations of Propionibacterium spp. and Actinomyces compared to those of the “balanced” group. Furthermore, in “stressed” facial skin a lowered microbiota diversity was observed underlining the fact that the remarkable decline of the microbiota diversity of a stressed condition may cause less abundant bacteria to disappear, resulting in a disturbance of the “balanced” condition’s microbiome. Afterwards, the yogurt-based formulation was applied four times over a 28-day period on imbalanced skin volunteers (D0, D7, D14, D28) and its ability to induce re-balancing effects on a “stressed” human face microbiome exhibiting dysbiosis was evaluated.

It is worth noting, that according to Howard et al., Lactobacillus and Cutibacterium (Propionibacterium) representation on the face’s microbiome demonstrated a statistically significant decrease with increasing age, compared to an increase in abundance of Staphylococcus and Corynebacterium among Caucasian women (41). Juge et al. reported that older aged Western European women displayed a significant decrease in Propionibacterium and Actinobacteria, with a simultaneous “striking increase” in Corynebacterium species compared to their younger counterparts (42). Several independent studies have reported comparable age-associated microbiome shifts across diverse cohorts in Western European, East Asian and North American populations. The similar patterns include decreases in Cutibacterium populations and an increase in Corynebacterium and, variably, Staphylococcus abundance (43-47). This could help explain the “stressed” facial appearance of the volunteers that participated in our study, since comparable results were reached.

Yogurt is a natural product that is produced with the fermentation of pasteurized milk with cultures of the bacteria Lactobacillus spp. and S. thermophilus and is considered a great probiotic (48, 49). Although studies on the benefits of topically applied whole yogurt formulations on the skin’s microbiome are limited, there is an increasing interest on how prebiotics and probiotics affect human health (50, 51). Streptococcus thermophilus can produce enzymes that, when applied topically, contribute to skin hydration, reducing skin dryness and loss of water and, consequently, decelerating the process of aging (52, 53). In vitro studies have, also, shown that S. thermophilus lysate has antifibrotic and antioxidant properties (54, 55). Likewise, in vitro and in vivo studies suggest Lactobacilli strains help improve skin hydration, elasticity and firmness, promote collagen synthesis and wound healing, reduce trans-epidermal water loss and inflammation and improve symptoms of photo-aging and skin diseases, such as acne and atopic dermatitis (28, 56-60). Both Lactobacilli and S. thermophilus bacteria have, also, shown to have antibacterial properties. This is possibly due to immunomodulation, and production of lactic acid, H2O2 and bacteriocin by those probiotics. This antibacterial activity has been shown to be effective against several pathogenic bacteria, including Staphylococcus aureus, Corynebacterium spp. and Escherichia Coli (61-70).

In accordance with these observations, our study concluded that following application of the yoghurt-based complex the overabundance of the opportunistic pathogens Staphylococci and Corynebacteria was reduced, while other beneficial bacteria, such as Propionibacterium, that were being suppressed started colonizing the skin again. Moreover, the lowered microbiota diversity in “stressed” facial samples, which was caused by the overgrowth of opportunistic microorganisms and leads to a deregulation of key functions, was gradually and steadily alleviated. This helped to stabilize the ecosystem and restore the homeostatic mechanisms of the skin.

Limitations. First, the small sample size of 31 volunteers limits the generalizability of the findings to broader populations. Additionally, investigation accrual of only four male volunteers prevents sex-based comparisons. Furthermore, the study did not account for environmental and lifestyle factors, such as the climate, diet, previous skincare routines and stress levels of the participants that may affect the final outcome. Further prospective studies including a larger cohort of participants will further amplify our results.

Conclusion

The study showcases the effects of application of a yogurt-based formula on “stressed” human facial skin. The yogurt-based complex seems to add to the restoration of the microbial equilibrium by reducing overrepresentation of certain bacteria species. This approach potentially counteracts the microbial disruption present in stressed skin, aiding a return to microbiota eubiosis and promotion of a “healthy- appearance” skin.

Footnotes

  • Authors’ Contributions

    Design and conception: L.A and A.K.A.; data collection: I.V., G.V., D.V.; data analysis and interpretation: all authors; drafting of the article: all authors. Overall supervision: L.A and A.K.A.. All Authors have read and agreed to the published version of the manuscript.

  • Conflicts of Interest

    G.S., A.L., C.S. and L.A. are employees of Korres SA. The company develops and markets skincare products including formulations related to the investigational product evaluated in the study. This study was sponsored by Korres SA. The sponsor had no role in data analysis, interpretation or the decision to publish.

  • Artificial Intelligence (AI) Disclosure

    No artificial intelligence (AI) tools, including large language models or machine learning software, were used in the preparation, analysis, or presentation of this manuscript.

  • Received December 24, 2025.
  • Revision received January 20, 2026.
  • Accepted February 17, 2026.
  • Copyright © 2026 The Author(s). Published by the International Institute of Anticancer Research.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

References

  1. ↵
    1. Lopez Ojeda W,
    2. Pandey A,
    3. Alhajj M,
    4. Oakley AM
    : Anatomy, skin (integument). In: StatPearls [Internet]. Treasure Island, FL, USA, StatPearls Publishing, 2022. Available at: https://www.ncbi.nlm.nih.gov/books/NBK441980/ [Last accessed on November 12, 2025]
  2. ↵
    1. Yousef H,
    2. Alhajj M,
    3. Fakoya AO,
    4. Sharma S
    : Anatomy, skin (integument), epidermis. In: StatPearls [Internet]. Treasure Island, FL, USA, StatPearls Publishing, 2024. Available at: https://www.ncbi.nlm.nih.gov/books/NBK470464/ [Last accessed on November 12, 2025]
  3. ↵
    1. Fredricks DN
    : Microbial ecology of human skin in health and disease. J Invest Dermatol Symp Proc 6(3): 167-169, 2001. DOI: 10.1046/j.0022-202x.2001.00039.x
    OpenUrlCrossRef
  4. ↵
    1. Grice EA,
    2. Segre JA
    : The skin microbiome. Nat Rev Microbiol 9(4): 244-253, 2011. DOI: 10.1038/nrmicro2537
    OpenUrlCrossRefPubMed
  5. ↵
    1. Byrd AL,
    2. Belkaid Y,
    3. Segre JA
    : The human skin microbiome. Nat Rev Microbiol 16(3): 143-155, 2018. DOI: 10.1038/nrmicro.2017.157
    OpenUrlCrossRefPubMed
  6. ↵
    1. Brandwein M,
    2. Fuks G,
    3. Israel A,
    4. Hodak E,
    5. Sabbah F,
    6. Steinberg D,
    7. Bentwich Z,
    8. Shental N,
    9. Meshner S
    : Biogeographical landscape of the human face skin microbiome viewed in high definition. Acta Derm Venereol 101(11): adv00603, 2021. DOI: 10.2340/00015555-3929
    OpenUrlCrossRefPubMed
  7. ↵
    1. Dréno B,
    2. Araviiskaia E,
    3. Berardesca E,
    4. Gontijo G,
    5. Sanchez Viera M,
    6. Xiang LF,
    7. Martin R,
    8. Bieber T
    : Microbiome in healthy skin, update for dermatologists. J Eur Acad Dermatol Venereol 30(12): 2038-2047, 2016. DOI: 10.1111/jdv.13965
    OpenUrlCrossRefPubMed
  8. ↵
    1. Arda O,
    2. Göksügür N,
    3. Tüzün Y
    : Basic histological structure and functions of facial skin. Clin Dermatol 32(1): 3-13, 2014. DOI: 10.1016/j.clindermatol.2013.05.021
    OpenUrlCrossRefPubMed
  9. ↵
    1. Oh J,
    2. Byrd AL,
    3. Deming C,
    4. Conlan S, NISC Comparative Sequencing Program,
    5. Kong HH,
    6. Segre JA
    : Biogeography and individuality shape function in the human skin metagenome. Nature 514(7520): 59-64, 2014. DOI: 10.1038/nature13786
    OpenUrlCrossRefPubMed
  10. ↵
    1. Grice EA,
    2. Kong HH,
    3. Conlan S,
    4. Deming CB,
    5. Davis J,
    6. Young AC, NISC Comparative Sequencing Program,
    7. Bouffard GG,
    8. Blakesley RW,
    9. Murray PR,
    10. Green ED,
    11. Turner ML,
    12. Segre JA
    : Topographical and temporal diversity of the human skin microbiome. Science 324(5931): 1190-1192, 2009. DOI: 10.1126/science.1171700
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Scharschmidt TC,
    2. Fischbach MA
    : What lives on our skin: ecology, genomics and therapeutic opportunities of the skin microbiome. Drug Discov Today Dis Mech 10(3-4): e83-e89, 2013. DOI: 10.1016/j.ddmec.2012.12.003
    OpenUrlCrossRefPubMed
  12. ↵
    1. Ma L,
    2. Zhang H,
    3. Jia Q,
    4. Bai T,
    5. Yang S,
    6. Wang M,
    7. Li Y,
    8. Shao L
    : Facial physiological characteristics and skin microbiomes changes are associated with body mass index (BMI). Clin Cosmet Investig Dermatol 17: 513-528, 2024. DOI: 10.2147/CCID.S447412
    OpenUrlCrossRefPubMed
  13. ↵
    1. Harris-Tryon TA,
    2. Grice EA
    : Microbiota and maintenance of skin barrier function. Science 376(6596): 940-945, 2022. DOI: 10.1126/science.abo0693
    OpenUrlCrossRefPubMed
  14. ↵
    1. Gallo RL,
    2. Nakatsuji T
    : Microbial symbiosis with the innate immune defense system of the skin. J Invest Dermatol 131(10): 1974-1980, 2011. DOI: 10.1038/jid.2011.182
    OpenUrlCrossRefPubMed
  15. ↵
    1. Du Y,
    2. Li B,
    3. Yang J,
    4. Zhang Y,
    5. Qi F,
    6. Meng H
    : Analysis of skin microbiome in facial and back acne patients based on high-throughput sequencing. J Cosmet Dermatol 24(6): e70259, 2025. DOI: 10.1111/jocd.70259
    OpenUrlCrossRefPubMed
  16. ↵
    1. Borrego-Ruiz A,
    2. Borrego JJ
    : Microbial dysbiosis in the skin microbiome and its psychological consequences. Microorganisms 12(9): 1908, 2024. DOI: 10.3390/microorganisms12091908
    OpenUrlCrossRefPubMed
  17. ↵
    1. Sanchez-Lopez MF,
    2. Barrero-Caicedo PA,
    3. Olmos-Carval HM,
    4. Torres-Medina AF,
    5. Alzate-Granados JP
    : Relationship between skin and gut microbiota dysbiosis and inflammatory skin diseases in adult patients: A systematic review. The Microbe 7: 100342, 2025. DOI: 10.1016/j.microb.2025.100342
    OpenUrlCrossRef
  18. ↵
    1. Pantermehl S,
    2. Foth A,
    3. Meyer E,
    4. Barbeck M,
    5. Jung O
    : In vitro cytocompatibility analysis and comparison of different hyaluronic acid fillers for minimally invasive esthetics. In Vivo 38(4): 1621-1635, 2024. DOI: 10.21873/invivo.13612
    OpenUrlAbstract/FREE Full Text
    1. Fowler JF Jr.,
    2. Woolery-Lloyd H,
    3. Waldorf H,
    4. Saini R
    : Innovations in natural ingredients and their use in skin care. J Drugs Dermatol 9(6 Suppl): S72-S83, 2010.
    OpenUrlPubMed
  19. ↵
    1. Liu JK
    : Natural products in cosmetics. Nat Prod Bioprospect 12(1): 40, 2022. DOI: 10.1007/s13659-022-00363-y
    OpenUrlCrossRefPubMed
  20. ↵
    1. LE LTT,
    2. Kim BK,
    3. Chien PN,
    4. Choi KW,
    5. Kim HB,
    6. Hwang UJ,
    7. Han HS,
    8. Heo CY
    : Investigating the anti-aging effects of caviar oil on human skin. In Vivo 37(5): 2078-2091, 2023. DOI: 10.21873/invivo.13305
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Rušanac A,
    2. Škibola Z,
    3. Matijašić M,
    4. Čipčić Paljetak H,
    5. Perić M
    : Microbiome-based products: therapeutic potential for inflammatory skin diseases. Int J Mol Sci 26(14): 6745, 2025. DOI: 10.3390/ijms26146745
    OpenUrlCrossRefPubMed
    1. Gao T,
    2. Wang X,
    3. Li Y,
    4. Ren F
    : The role of probiotics in skin health and related gut-skin axis: a review. Nutrients 15(14): 3123, 2023. DOI: 10.3390/nu15143123
    OpenUrlCrossRef
  22. ↵
    1. Al-Smadi K,
    2. Leite-Silva VR,
    3. Filho NA,
    4. Lopes PS,
    5. Mohammed Y
    : Innovative approaches for maintaining and enhancing skin health and managing skin diseases through microbiome-targeted strategies. Antibiotics (Basel) 12(12): 1698, 2023. DOI: 10.3390/antibiotics12121698
    OpenUrlCrossRefPubMed
  23. ↵
    1. Al-Ghazzewi F,
    2. Tester R
    : Impact of prebiotics and probiotics on skin health. Benef Microbes 5(2): 99-107, 2014. DOI: 10.3920/BM2013.0040
    OpenUrlCrossRefPubMed
  24. ↵
    1. Ito Y,
    2. Amagai M
    : Controlling skin microbiome as a new bacteriotherapy for inflammatory skin diseases. Inflamm Regen 42(1): 26, 2022. DOI: 10.1186/s41232-022-00212-y
    OpenUrlCrossRefPubMed
  25. ↵
    1. Navarro-López V,
    2. Núñez-Delegido E,
    3. Ruzafa-Costas B,
    4. Sánchez-Pellicer P,
    5. Agüera-Santos J,
    6. Navarro-Moratalla L
    : Probiotics in the therapeutic arsenal of dermatologists. Microorganisms 9(7): 1513, 2021. DOI: 10.3390/microorganisms9071513
    OpenUrlCrossRefPubMed
  26. ↵
    1. Habeebuddin M,
    2. Karnati RK,
    3. Shiroorkar PN,
    4. Nagaraja S,
    5. Asdaq SMB,
    6. Khalid Anwer M,
    7. Fattepur S
    : Topical probiotics: more than a skin deep. Pharmaceutics 14(3): 557, 2022. DOI: 10.3390/pharmaceutics14030557
    OpenUrlCrossRefPubMed
  27. ↵
    1. Sandhu SS,
    2. Pourang A,
    3. Sivamani RK
    : A review of next generation sequencing technologies used in the evaluation of the skin microbiome: what a time to be alive. Dermatol Online J 25(7), 2019.
  28. ↵
    1. Wensel CR,
    2. Pluznick JL,
    3. Salzberg SL,
    4. Sears CL
    : Next-generation sequencing: insights to advance clinical investigations of the microbiome. J Clin Invest 132(7): e154944, 2022. DOI: 10.1172/JCI154944
    OpenUrlCrossRefPubMed
  29. ↵
    1. Marchesi JR,
    2. Ravel J
    : The vocabulary of microbiome research: a proposal. Microbiome 3: 31, 2015. DOI: 10.1186/s40168-015-0094-5
    OpenUrlCrossRefPubMed
  30. ↵
    1. Ederveen THA,
    2. Smits JPH,
    3. Boekhorst J,
    4. Schalkwijk J,
    5. van den Bogaard EH,
    6. Zeeuwen PLJM
    : Skin microbiota in health and disease: From sequencing to biology. J Dermatol 47(10): 1110-1118, 2020. DOI: 10.1111/1346-8138.15536
    OpenUrlCrossRefPubMed
  31. ↵
    1. Utturkar S,
    2. Dassanayake A,
    3. Nagaraju S,
    4. Brown SD
    : Bacterial differential expression analysis methods. Methods Mol Biol 2096: 89-112, 2020. DOI: 10.1007/978-1-0716-0195-2_8
    OpenUrlCrossRefPubMed
  32. ↵
    1. Dong X,
    2. Kleiner M,
    3. Sharp CE,
    4. Thorson E,
    5. Li C,
    6. Liu D,
    7. Strous M
    : Fast and simple analysis of MiSeq amplicon sequencing data with MetaAmp. Front Microbiol 8: 1461, 2017. DOI: 10.3389/fmicb.2017.01461
    OpenUrlCrossRefPubMed
  33. ↵
    1. Izhari MA,
    2. Al Mutawa OA,
    3. Mahzari A,
    4. Alotaibi EA,
    5. Almashary MA,
    6. Alshahrani JA,
    7. Gosady ARA,
    8. Almutairi AM,
    9. Dardari DMM,
    10. AlGarni AKA
    : Helicobacter pylori (H. pylori) infection-associated dyslipidemia in the Asir region of Saudi Arabia. Life (Basel) 13(11): 2206, 2023. DOI: 10.3390/life13112206
    OpenUrlCrossRefPubMed
  34. ↵
    1. Chiller K,
    2. Selkin BA,
    3. Murakawa GJ
    : Skin microflora and bacterial infections of the skin. J Invest Dermatol Symp Proc 6(3): 170-174, 2001. DOI: 10.1046/j.0022-202x.2001.00043.x
    OpenUrlCrossRef
  35. ↵
    1. Totté JEE,
    2. van Doorn MB,
    3. Pasmans SGMA
    : Successful treatment of chronic staphylococcus aureus-related dermatoses with the topical endolysin Staphefekt SA.100: a report of 3 cases. Case Rep Dermatol 9(2): 19-25, 2017. DOI: 10.1159/000473872
    OpenUrlCrossRefPubMed
    1. Verbanic S,
    2. Shen Y,
    3. Lee J,
    4. Deacon JM,
    5. Chen IA
    : Microbial predictors of healing and short-term effect of debridement on the microbiome of chronic wounds. NPJ Biofilms Microbiomes 6(1): 21, 2020. DOI: 10.1038/s41522-020-0130-5
    OpenUrlCrossRefPubMed
  36. ↵
    1. Townsend EC,
    2. Kalan LR
    : The dynamic balance of the skin microbiome across the lifespan. Biochem Soc Trans 51(1): 71-86, 2023. DOI: 10.1042/BST20220216
    OpenUrlCrossRefPubMed
  37. ↵
    1. Bouslimani A,
    2. da Silva R,
    3. Kosciolek T,
    4. Janssen S,
    5. Callewaert C,
    6. Amir A,
    7. Dorrestein K,
    8. Melnik AV,
    9. Zaramela LS,
    10. Kim JN,
    11. Humphrey G,
    12. Schwartz T,
    13. Sanders K,
    14. Brennan C,
    15. Luzzatto-Knaan T,
    16. Ackermann G,
    17. McDonald D,
    18. Zengler K,
    19. Knight R,
    20. Dorrestein PC
    : The impact of skin care products on skin chemistry and microbiome dynamics. BMC Biol 17(1): 47, 2019. DOI: 10.1186/s12915-019-0660-6
    OpenUrlCrossRefPubMed
  38. ↵
    1. Howard B,
    2. Bascom CC,
    3. Hu P,
    4. Binder RL,
    5. Fadayel G,
    6. Huggins TG,
    7. Jarrold BB,
    8. Osborne R,
    9. Rocchetta HL,
    10. Swift D,
    11. Tiesman JP,
    12. Song Y,
    13. Wang Y,
    14. Wehmeyer K,
    15. Kimball AB,
    16. Isfort RJ
    : Aging-associated changes in the adult human skin microbiome and the host factors that affect skin microbiome composition. J Invest Dermatol 142(7): 1934-1946.e21, 2022. DOI: 10.1016/j.jid.2021.11.029
    OpenUrlCrossRefPubMed
  39. ↵
    1. Jugé R,
    2. Rouaud-Tinguely P,
    3. Breugnot J,
    4. Servaes K,
    5. Grimaldi C,
    6. Roth MP,
    7. Coppin H,
    8. Closs B
    : Shift in skin microbiota of Western European women across aging. J Appl Microbiol 125(3): 907-916, 2018. DOI: 10.1111/jam.13929
    OpenUrlCrossRef
  40. ↵
    1. Shibagaki N,
    2. Suda W,
    3. Clavaud C,
    4. Bastien P,
    5. Takayasu L,
    6. Iioka E,
    7. Kurokawa R,
    8. Yamashita N,
    9. Hattori Y,
    10. Shindo C,
    11. Breton L,
    12. Hattori M
    : Aging-related changes in the diversity of women’s skin microbiomes associated with oral bacteria. Sci Rep 7(1): 10567, 2017. DOI: 10.1038/s41598-017-10834-9
    OpenUrlCrossRefPubMed
    1. Dimitriu PA,
    2. Iker B,
    3. Malik K,
    4. Leung H,
    5. Mohn WW,
    6. Hillebrand GG
    : New Insights into the Intrinsic and Extrinsic Factors That Shape the Human Skin Microbiome. mBio 10(4): e00839-19, 2019. DOI: 10.1128/mBio.00839-19
    OpenUrlCrossRef
    1. Kim HJ,
    2. Kim JJ,
    3. Myeong NR,
    4. Kim T,
    5. Kim D,
    6. An S,
    7. Kim H,
    8. Park T,
    9. Jang SI,
    10. Yeon JH,
    11. Kwack I,
    12. Sul WJ
    : Segregation of age-related skin microbiome characteristics by functionality. Sci Rep 9(1): 16748, 2019. DOI: 10.1038/s41598-019-53266-3
    OpenUrlCrossRefPubMed
    1. Kim HJ,
    2. Oh HN,
    3. Park T,
    4. Kim H,
    5. Lee HG,
    6. An S,
    7. Sul WJ
    : Aged related human skin microbiome and mycobiome in Korean women. Sci Rep 12(1): 2351, 2022. DOI: 10.1038/s41598-022-06189-5
    OpenUrlCrossRefPubMed
  41. ↵
    1. Garlet A,
    2. Andre-Frei V,
    3. Del Bene N,
    4. Cameron HJ,
    5. Samuga A,
    6. Rawat V,
    7. Ternes P,
    8. Leoty-Okombi S
    : Facial skin microbiome composition and functional shift with aging. Microorganisms 12(5): 1021, 2024. DOI: 10.3390/microorganisms12051021
    OpenUrlCrossRefPubMed
  42. ↵
    1. Codex Alimentarius Commission
    . Milk and Milk Products. 2nd ed. Rome: Food and Agriculture Organization of the United Nations & World Health Organization; 2011. Available at: https://www.fao.org/4/i2085e/i2085e00.pdf [Last accessed on November 12, 2025]
  43. ↵
    1. Hadjimbei E,
    2. Botsaris G,
    3. Chrysostomou S
    : Beneficial effects of yoghurts and probiotic fermented milks and their functional food potential. Foods 11(17): 2691, 2022. DOI: 10.3390/foods11172691
    OpenUrlCrossRefPubMed
  44. ↵
    1. Vaughn AR,
    2. Sivamani RK
    : Effects of fermented dairy products on skin: a systematic review. J Altern Complement Med 21(7): 380-385, 2015. DOI: 10.1089/acm.2014.0261
    OpenUrlCrossRefPubMed
  45. ↵
    1. Lolou V,
    2. Panayiotidis MI
    : Functional role of probiotics and prebiotics on skin health and disease. Fermentation 5(2): 41, 2019. DOI: 10.3390/fermentation5020041
    OpenUrlCrossRef
  46. ↵
    1. DiMarzio L,
    2. Cinque B,
    3. Cupelli F,
    4. De Simone C,
    5. Cifone M,
    6. Giuliani M
    : Increase of skin-ceramide levels in aged subjects following a short-term topical application of bacterial sphingomyelinase from Streptococcus Thermophilus. Int J Immunopathol Pharmacol 21(1): 137-143, 2008. DOI: 10.1177/039463200802100115
    OpenUrlCrossRefPubMed
  47. ↵
    1. Cinque B,
    2. Palumbo P,
    3. La Torre C,
    4. Melchiorre E,
    5. Corridoni D,
    6. Miconi G,
    7. Di Marzio L,
    8. Cifone MG,
    9. Giuliani M
    : Probiotics in aging skin. Textbook of Aging Skin: 1315-1327, 2017. DOI: 10.1007/978-3-662-47398-6_78
    OpenUrlCrossRef
  48. ↵
    1. Lombardi F,
    2. Augello FR,
    3. Artone S,
    4. Bahiti B,
    5. Sheldon JM,
    6. Giuliani M,
    7. Cifone MG,
    8. Palumbo P,
    9. Cinque B
    : Efficacy of probiotic Streptococcus thermophilus in counteracting TGF-β1-induced fibrotic response in normal human dermal fibroblasts. J Inflamm (Lond) 19(1): 27, 2022. DOI: 10.1186/s12950-022-00324-9
    OpenUrlCrossRefPubMed
  49. ↵
    1. Augello FR,
    2. Lombardi F,
    3. Ciafarone A,
    4. Altamura S,
    5. Marazzato M,
    6. Artone S,
    7. Cinque B,
    8. Palumbo P
    : Streptococcus thermophilus CNCM I-5570 lysate counteracts the aging process in human dermal fibroblast cells by neutralizing harmful free radicals and impacting antioxidant and anti-inflammatory pathways, thus restoring their physiological functions. Biomed Pharmacother 185: 117975, 2025. DOI: 10.1016/j.biopha.2025.117975
    OpenUrlCrossRefPubMed
  50. ↵
    1. Falholt Elvebakken H,
    2. Bruntse AB,
    3. Vedel C,
    4. Kjaerulff S
    : Topical Lactiplantibacillus plantarum LB244R® ointment alleviates skin aging: An exploratory trial. J Cosmet Dermatol 22(6): 1911-1918, 2023. DOI: 10.1111/jocd.15657
    OpenUrlCrossRefPubMed
    1. Tsai WH,
    2. Chou CH,
    3. Chiang YJ,
    4. Lin CG,
    5. Lee CH
    : Regulatory effects of Lactobacillus plantarum-GMNL6 on human skin health by improving skin microbiome. Int J Med Sci 18(5): 1114-1120, 2021. DOI: 10.7150/ijms.51545
    OpenUrlCrossRefPubMed
    1. Butler É,
    2. Lundqvist C,
    3. Axelsson J
    : Lactobacillus reuteri DSM 17938 as a novel topical cosmetic ingredient: a proof of concept clinical study in adults with atopic dermatitis. Microorganisms 8(7): 1026, 2020. DOI: 10.3390/microorganisms8071026
    OpenUrlCrossRefPubMed
    1. Flint E,
    2. Ahmad N,
    3. Rowland K,
    4. Hildebolt C,
    5. Raskin D
    : Topical probiotics reduce atopic dermatitis severity: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials. Cureus 16(9): e70001, 2024. DOI: 10.7759/cureus.70001
    OpenUrlCrossRefPubMed
  51. ↵
    1. Prakoeswa CRS,
    2. Bonita L,
    3. Karim A,
    4. Herwanto N,
    5. Umborowati MA,
    6. Setyaningrum T,
    7. Hidayati AN,
    8. Surono IS
    : Beneficial effect of Lactobacillus plantarum IS-10506 supplementation in adults with atopic dermatitis: a randomized controlled trial. J Dermatol Treat 33(3): 1491-1498, 2022. DOI: 10.1080/09546634.2020.1836310
    OpenUrlCrossRef
  52. ↵
    1. Akpinar A,
    2. Yerlikaya O,
    3. Kılıç S
    : Antimicrobial activity and antibiotic resistance of Lactobacillus delbrueckii ssp. bulgaricus and Streptococcus thermophilus strains isolated from Turkish homemade yoghurts. Afr J Microbiol Res 5(6): 675-682, 2011.
    OpenUrl
    1. Abedi D,
    2. Feizizadeh S,
    3. Akbari V,
    4. Jafarian-Dehkordi A
    : In vitro anti-bacterial and anti-adherence effects of Lactobacillus delbrueckii subsp. bulgaricus on Escherichia coli. Res Pharm Sci 8(4): 260-268, 2013.
    OpenUrlPubMed
    1. Rossi F,
    2. Marzotto M,
    3. Cremonese S,
    4. Rizzotti L,
    5. Torriani S
    : Diversity of Streptococcus thermophilus in bacteriocin production; inhibitory spectrum and occurrence of thermophilin genes. Food Microbiol 35(1): 27-33, 2013. DOI: 10.1016/j.fm.2013.02.006
    OpenUrlCrossRefPubMed
    1. Miteva V,
    2. Stefanova T,
    3. Budakov I,
    4. Ivanova I,
    5. Mitev V,
    6. Gancheva A,
    7. Ljubenov M
    : Characterization of bacteriocins produced by strains from traditional Bulgarian dairy products. Syst Appl Microbiol 21(1): 151-161, 1998. DOI: 10.1016/S0723-2020(98)80019-2
    OpenUrlCrossRefPubMed
    1. Kim HJ,
    2. Kim JH,
    3. Son JH,
    4. Seo HJ,
    5. Park SJ,
    6. Paek NS,
    7. Kim SK
    : Characterization of bacteriocin produced by Lactobacillus bulgaricus. J Microbiol Biotechnol 14(3): 503-508, 2004.
    OpenUrl
    1. Emokpae I,
    2. Tobia DL,
    3. Stamm SD,
    4. Lundy P,
    5. Weimer DS,
    6. Demory Beckler M
    : Examining the efficacy of five lactobacillus species in treating and preventing atopic dermatitis: a systemic literature review. Cureus 16(7): e64833, 2024. DOI: 10.7759/cureus.64833
    OpenUrlCrossRefPubMed
    1. Ding YH,
    2. Qian LY,
    3. Pang J,
    4. Lin JY,
    5. Xu Q,
    6. Wang LH,
    7. Huang DS,
    8. Zou H
    : The regulation of immune cells by Lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy. Oncotarget 8(35): 59915-59928, 2017. DOI: 10.18632/oncotarget.18346
    OpenUrlCrossRefPubMed
    1. Lebeer S,
    2. Oerlemans EFM,
    3. Claes I,
    4. Henkens T,
    5. Delanghe L,
    6. Wuyts S,
    7. Spacova I,
    8. van den Broek MFL,
    9. Tuyaerts I,
    10. Wittouck S,
    11. De Boeck I,
    12. Allonsius CN,
    13. Kiekens F,
    14. Lambert J
    : Selective targeting of skin pathobionts and inflammation with topically applied lactobacilli. Cell Rep Med 3(2): 100521, 2022. DOI: 10.1016/j.xcrm.2022.100521
    OpenUrlCrossRef
    1. Marty-Teysset C,
    2. de la Torre F,
    3. Garel J
    : Increased production of hydrogen peroxide by Lactobacillus delbrueckii subsp. bulgaricus upon aeration: involvement of an NADH oxidase in oxidative stress. Appl Environ Microbiol 66(1): 262-267, 2000. DOI: 10.1128/AEM.66.1.262-267.2000
    OpenUrlAbstract/FREE Full Text
  53. ↵
    1. Li P,
    2. Chen S,
    3. Li P,
    4. Xu D,
    5. Tang X,
    6. Liao J,
    7. Xie H,
    8. Li G,
    9. Kuang Y,
    10. Su J,
    11. Tang S,
    12. Zhou J
    : Treatment of axillary osmidrosis by rebalancing skin microecology with Lactobacillus bulgaricus. Front Microbiol 13: 821696, 2022. DOI: 10.3389/fmicb.2022.821696
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

In Vivo: 40 (3)
In Vivo
Vol. 40, Issue 3
May-June 2026
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effects of a Greek Yoghurt-based Complex on the Human Facial Skin Microbiome
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Effects of a Greek Yoghurt-based Complex on the Human Facial Skin Microbiome
IOANNIS VOYIATZIS, GIANNIS VATSELLAS, DIMITRIS VALAKOS, GEORGIOS STAVROPOULOS, AGGELIKI LAMIA, CHRYSSOULA STAMATOGIANNI, EMMANOUIL ATHANASIADIS, ATHANASIOS K. ANAGNOSTOPOULOS, LIDA ALEXIOU
In Vivo May 2026, 40 (3) 1852-1863; DOI: 10.21873/invivo.14339

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Effects of a Greek Yoghurt-based Complex on the Human Facial Skin Microbiome
IOANNIS VOYIATZIS, GIANNIS VATSELLAS, DIMITRIS VALAKOS, GEORGIOS STAVROPOULOS, AGGELIKI LAMIA, CHRYSSOULA STAMATOGIANNI, EMMANOUIL ATHANASIADIS, ATHANASIOS K. ANAGNOSTOPOULOS, LIDA ALEXIOU
In Vivo May 2026, 40 (3) 1852-1863; DOI: 10.21873/invivo.14339
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • When Vasculitis Is Not Vasculitis: A Case Report in Which Dynamic Immunophenotyping Revealed Hidden Angioimmunoblastic T-cell Lymphoma
  • Management of a Complex Orbital Post-transplantation Lymphoproliferative Disorder: A Case Report and Literature Review
  • Adjunctive Molecular Hydrogen Capsule Therapy in Empyema Complicated by Chronic Inflammatory Demyelinating Polyneuropathy: A Case Report
Show more Case Reports

Keywords

  • Facial skin
  • microbiome
  • yoghurt-based complex
  • NGS
  • 16S rRNA sequencing
  • skin amelioration
In Vivo

© 2026 In Vivo

Powered by HighWire